These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1431011)

  • 1. Serotonin in affective disorders.
    Grahame-Smith DG
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():5-13. PubMed ID: 1431011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on central nervous system serotonin receptors in mood disorders.
    Young A; Goodwin GM
    Ann Acad Med Singap; 1991 Jan; 20(1):46-50. PubMed ID: 2029163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin function in affective disorders.
    Grahame-Smith DG
    Acta Psychiatr Scand Suppl; 1989; 350():7-12. PubMed ID: 2683591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serotonin in depression and anxiety.
    Baldwin D; Rudge S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():41-5. PubMed ID: 7622823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk.
    Escolar G; Díaz-Ricart M; Gomez-Gil E; Serra M; Gasto C; Bozzo J; Galán AM
    Drugs Today (Barc); 2005 Nov; 41(11):721-43. PubMed ID: 16395413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes.
    Lesch KP; Mössner R
    Handb Exp Pharmacol; 2006; (175):417-56. PubMed ID: 16722245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders.
    Ogren SO; Razani H; Elvander-Tottie E; Kehr J
    Physiol Behav; 2007 Sep; 92(1-2):172-9. PubMed ID: 17585970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain.
    Bauer M; Heinz A; Whybrow PC
    Mol Psychiatry; 2002; 7(2):140-56. PubMed ID: 11840307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
    Skelin I; Yamane F; Diksic M
    Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of chronic paroxetine on 5-HT1A control of dorsal raphe cell firing and 5-HT release.
    Davidson C; Stamford JA
    Neuroreport; 1998 Aug; 9(11):2535-8. PubMed ID: 9721928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease.
    Coates MD; Tekin I; Vrana KE; Mawe GM
    Aliment Pharmacol Ther; 2017 Sep; 46(6):569-580. PubMed ID: 28737264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.
    Jing F; Zhang J
    Dig Dis Sci; 2014 Nov; 59(11):2642-8. PubMed ID: 24916714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery.
    Robson MJ; Quinlan MA; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):932-942. PubMed ID: 28345868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine in the central nervous system.
    Chojnacka-Wójcik E
    Pol J Pharmacol; 1995; 47(3):219-35. PubMed ID: 8714755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.